TrialCell reports. Medicine2022

Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant.

Kirsten E Lyke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.